Mylan Faces $100M Tax Bill Over Drug Agreement With Forest
Mylan Inc. is protesting an Internal Revenue Service determination finding it owes the U.S. government $100 million in taxes arising from a drug development agreement with Forest Laboratories Holdings Ltd., in...To view the full article, register now.
Already a subscriber? Click here to view full article